- Home
- CRMD vs IFN Comparison
CRMD vs IFN Comparison
Compare CRMD & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | IFN |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 561.8M | 540.6M |
| IPO Year | 2009 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CRMD | IFN |
|---|---|---|
| Price | $6.93 | $12.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 254.2K |
| Earning Date | 04-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.03 | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $43,472,170.00 | N/A |
| Revenue This Year | $627.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.51 | ★ N/A |
| Revenue Growth | ★ 66363.08 | N/A |
| 52 Week Low | $5.60 | $12.51 |
| 52 Week High | $17.43 | $16.60 |
Technical Indicators
Market Signals| Indicator | CRMD | IFN |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 22.00 |
| Support Level | $6.55 | N/A |
| Resistance Level | $8.53 | $14.08 |
| Average True Range (ATR) | 0.28 | 0.18 |
| MACD | 0.06 | -0.11 |
| Stochastic Oscillator | 12.17 | 13.41 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.